Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Hormone replacement therapy (HRT), also known as menopausal hormone therapy (MHT) or postmenopausal hormone therapy (PHT, PMHT), is a form of hormone therapy which is used to treat symptoms associated with menopause in women.These symptoms can include hot flashes, vaginal atrophy and dryness, and bone loss, among others, and are caused by diminished levels of sex hormones in the menopausal period.The main hormonal medications used in HRT for menopausal symptoms are estrogens and progestogens.A progestogen is usually used in combination with an estrogen in women with intact uteruses because unopposed estrogen therapy is associated with endometrial hyperplasia and cancer and progestogens prevent these risks.Androgens like testosterone are sometimes used in HRT as well.HRT medications are available in various forms and for use by a variety of different routes of administration.
This report elaborates the market size, market characteristics, and market growth of the Hormone Replacement Therapy (HRT) industry, and breaks down according to the type, application, and consumption area of Hormone Replacement Therapy (HRT). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Hormone Replacement Therapy (HRT) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Hormone Replacement Therapy (HRT) market covered in Chapter 13:
Genentech
Novo Nordisk
Novartis
Eli Lily
Mylan Laboratories
Bayer
Merck & Co.
Wyeth
Pfizer
Amgen
Abbott Laboratories
In Chapter 6, on the basis of types, the Hormone Replacement Therapy (HRT) market from 2015 to 2025 is primarily split into:
Oral
Parenteral
Transdermal
Others
In Chapter 7, on the basis of applications, the Hormone Replacement Therapy (HRT) market from 2015 to 2025 covers:
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
2019
This report elaborates the market size, market characteristics, and market growth of the Hormone Replacement Therapy (HRT) industry, and breaks down according to the type, application, and consumption area of Hormone Replacement Therapy (HRT). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Hormone Replacement Therapy (HRT) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Hormone Replacement Therapy (HRT) market covered in Chapter 13:
Genentech
Novo Nordisk
Novartis
Eli Lily
Mylan Laboratories
Bayer
Merck & Co.
Wyeth
Pfizer
Amgen
Abbott Laboratories
In Chapter 6, on the basis of types, the Hormone Replacement Therapy (HRT) market from 2015 to 2025 is primarily split into:
Oral
Parenteral
Transdermal
Others
In Chapter 7, on the basis of applications, the Hormone Replacement Therapy (HRT) market from 2015 to 2025 covers:
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
